Abstract:ABSTRACT The incidence of isoniazid (INH) resistant Mycobacterium tuberculosis is increasing globally. This study aimed to identify the molecular mechanisms behind the development of INH resistance in M. tuberculosis strains collected from the same patients during the standard course of treatment. Three M. tuberculosis strains were collected from a patient before and during antituberculosis (anti-TB) therapy. The strains were characterized using phenotypic drug susceptibility tests, Mycobacterial Interspersed Repeated Unit-Variable-Number Tandem Repeats (MIRU-VNTR), and whole-genome sequencing (WGS) to identify mutations associated with INH resistance. To validate the role of the novel mutations in INH resistance, the mutated katG genes were electroporated into a KatG-deleted M. tuberculosis strain (GA03). Three-dimensional structures of mutated KatG were modeled to predict their impact on INH binding. The pre-treatment strain was susceptible to INH. However, two INH-resistant strains were isolated from the patient after anti-TB therapy. MIRU-VNTR and WGS revealed that the three strains were clonally identical. A missense mutation (P232L) and a nonsense mutation (Q461Stop) were identified in the katG of the two post-treatment strains, respectively. Transformation experiments showed that katG of the pre-treatment strain restored INH susceptibility in GA03, whereas the mutated katG genes from the post-treatment strains rendered negative catalase activity and INH resistance. The protein model indicated that P232L reduced INH-KatG binding affinity while Q461Stop truncated gene transcription. Our results showed that the two katG mutations, P232L and Q461Stop, accounted for the co-emergence of INH-resistant clones during anti-TB therapy. The inclusion of these mutations in the design of molecular assays could increase the diagnostic performance. IMPORTANCE The evolution of drug-resistant strains of Mycobacterium tuberculosis within the lung lesions of a patient has a detrimental impact on treatment outcomes. This is particularly concerning for isoniazid (INH), which is the most potent first-line antimycobacterial drug. However, the precise genetic factors responsible for drug resistance in patients have not been fully elucidated, with approximately 15% of INH-resistant strains harboring unknown genetic factors. This raises concerns about the emergence of drug-resistant clones within patients, further contributing to the global epidemic of resistance. In this study, we revealed the presence of two novel katG mutations, which emerged independently due to the stress exerted by antituberculosis (anti-TB) treatment on a parental strain. Importantly, we experimentally demonstrated the functional significance of both mutations in conferring resistance to INH. Overall, this research sheds light on the genetic mechanisms underlying the evolution of INH resistance within patients and provides valuable insights for improving diagnostic performance by targeting specific mutations.

[Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].

Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium Tuberculosis Isolates from China.

Genotypic Characterization of Katg, Inha, and Ahpc in Isoniazid-Resistant Mycobacterium Tuberculosis Clinical Isolates in Shanghai, China

A Systematic Review of Mutations Associated with Isoniazid Resistance Points to Lower Diagnostic Sensitivity for Common Mutations and Increased Incidence of Uncommon Mutations in Clinical Strains of Mycobacterium tuberculosis

[Relationship Between INH-resistance and Katg Mutation in M. Tuberculosis].

Study on Mutations of Katg Genes in Mycobacterium Tuberculosis Isoniazid-Resistant Isolates

Detection of the isoniazid-resistant katG gene of Mycobacterium tuberculosis

Genome-wide SNP and InDel Mutations in Mycobacterium Tuberculosis Associated with Rifampicin and Isoniazid Resistance.

Missense Mutations of KatG Gene and Its Relationship with Isoniazid-Resistance in M.tuberculosis

Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.

Rapid detecting a point mutation of the Mycobacterium tuberculosis catalase-peroxidase ( katG ) gene associated with isoniazid resistance

Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy

Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China

The Investigation of the Variability of Katg Gene in Mycobacterium Tuberculosis

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India

Establishment and Application of Multi-Pcr-sscp Assay for Rapid Detection of Isoniazid- and Rifampin-Resistance Mycobacterium Tuberculosis Isolates

Mycobacterium Tuberculosis Rrs A1401G Mutation Correlates with High-Level Resistance to Kanamycin, Amikacin, and Capreomycin in Clinical Isolates from Mainland China

Characterization and Rapid Detection of Mutations in rpoB,KatG Gene of Clinical Isolates Mycobacterium bovis

Mutation Asn329Val in katG gene of Mycobacteria tuberculosis conferring resistance to Isoniazid

The Effect of Point Mutation of KatG Gene on the Catalase Activity Associated with INH Resistance by Site-Directed Mutagenesis

Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Mycobacterium Tuberculosis Isolated from China